GLASEEQ Trademark

Trademark Overview


On Wednesday, March 25, 2015, a trademark application was filed for GLASEEQ with the United States Patent and Trademark Office. The USPTO has given the GLASEEQ trademark a serial number of 79168312. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, May 7, 2024. This trademark is owned by Novartis AG. The GLASEEQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
glaseeq

General Information


Serial Number79168312
Word MarkGLASEEQ
Filing DateWednesday, March 25, 2015
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, May 7, 2024
Registration Number4843539
Registration DateTuesday, November 3, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 18, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, June 4, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Wednesday, July 8, 2015ASSIGNED TO EXAMINER
Thursday, July 2, 2015SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Tuesday, July 7, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, July 8, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 9, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 14, 2015APPLICATION FILING RECEIPT MAILED
Wednesday, July 29, 2015NOTICE OF PUBLICATION
Wednesday, August 12, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 12, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, August 18, 2015PUBLISHED FOR OPPOSITION
Friday, August 28, 2015NOTIFICATION PROCESSED BY IB
Tuesday, November 3, 2015REGISTERED-PRINCIPAL REGISTER
Thursday, December 3, 2015GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Thursday, January 28, 2016GENERIC MADRID TRANSACTION CREATED
Thursday, January 28, 2016GENERIC MADRID TRANSACTION SENT TO IB
Friday, March 11, 2016NOTIFICATION PROCESSED BY IB
Friday, June 22, 2018DEATH OF INTERNATIONAL REGISTRATION
Friday, June 22, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, March 1, 2019NOTIFICATION PROCESSED BY IB
Tuesday, May 28, 2024DEATH OF INTERNATIONAL REGISTRATION
Tuesday, May 28, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED